What question did this study set out to answer?

The review aims to illuminate the clinicopathologic spectrum and molecular insights into primary cutaneous lymphomas (PCLs).

December 19, 2025Open Access

Dermatologic Perspectives on Primary Cutaneous Lymphomas: Clinicopathologic Spectrum, Molecular Insights and Evolving Treatment Paradigms

View Full Paper

Ask AI

Bookmark

Authors

Narrative review highlights evolving paradigms in diagnosing primary cutaneous lymphomas, suggesting targeted therapies can improve outcomes.

The review aims to illuminate the clinicopathologic spectrum and molecular insights into primary cutaneous lymphomas (PCLs).
Narrative review from a dermatologic perspective
Discusses classification, epidemiology, and features of PCL subtypes
Reviews diagnostic and staging approaches alongside therapy options
Highlights key molecular drivers of cutaneous T-cell and B-cell lymphomas
Emphasizes the role of skin-directed therapies and immune therapies like brentuximab vedotin
Addresses unmet needs in diagnosis and management of advanced disease

Crespi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Narrative review highlights evolving paradigms in diagnosing primary cutaneous lymphomas, suggesting targeted therapies can improve outcomes.